NCT07407933 2026-04-09
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2 Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Fundación GECP
Fundación GECP